In June 2023, the FDA issued a warning that unapproved versions of GLP-1 drugs "can be risky for patients, as unapproved versions do not undergo FDAs review for safety, effectiveness and quality before they are marketed." The GLP-1 drug market has been dominated by pharmaceutical giant Novo Nordisk
Mineral and electrolyte metabolism
"Regulation of selenoprotein GPx4 expression and activity in human endothelial cells by fatty acids, cytokines and antioxidants"
If you purchase any of these products, we may earn a commission
If you sit in the insulin-resistant subgroup (the majority of women with PCOS, often with weight challenges and elevated fasting insulin), inositol, NAC, chromium picolinate, and omega-3 are likely your most evidence-aligned options
Coursey TG, Henriksson JT, Marcano DC, Shin CS, Isenhart LC, Ahmed F, et al